Sustained Hyperglycemia and Its Relationship with the Outcome of Hospitalized Patients with Severe COVID-19: Potential Role of ACE2 Upregulation.

Autor: Vargas-Rodriguez JR; Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Campus UAZ siglo XXI-L1, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico., Valdés Aguayo JJ; Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Campus UAZ siglo XXI-L1, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico., Garza-Veloz I; Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Campus UAZ siglo XXI-L1, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico., Martinez-Rendon J; Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Campus UAZ siglo XXI-L1, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico., Del Refugio Rocha Pizaña M; Escuela de Ingenieria y Ciencias, Tecnologico de Monterrey Campus Puebla, Puebla 72453, Mexico., Cabral-Pacheco GA; Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Campus UAZ siglo XXI-L1, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico., Juárez-Alcalá V; Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Campus UAZ siglo XXI-L1, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico., Martinez-Fierro ML; Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y C.S, Campus UAZ siglo XXI-L1, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.
Jazyk: angličtina
Zdroj: Journal of personalized medicine [J Pers Med] 2022 May 17; Vol. 12 (5). Date of Electronic Publication: 2022 May 17.
DOI: 10.3390/jpm12050805
Abstrakt: Chronic hyperglycemia increases the risk of developing severe COVID-19 symptoms, but the related mechanisms are unclear. A mean glucose level upon hospital admission >166 mg/dl correlates positively with acute respiratory distress syndrome in patients with hyperglycemia. The objective of this study was to evaluate the relationship between sustained hyperglycemia and the outcome of hospitalized patients with severe COVID-19. We also evaluated the effect of high glucose concentrations on the expression of angiotensin-converting enzyme 2 (ACE2). We carried out a case-control study with hospitalized patients with severe COVID-19 with and without sustained hyperglycemia. In a second stage, we performed in vitro assays evaluating the effects of high glucose concentrations on ACE2 gene expression. Fifty hospitalized patients with severe COVID-19 were included, of which 28 (56%) died and 22 (44%) recovered. Patients who died due to COVID-19 and COVID-19 survivors had a high prevalence of hyperglycemia (96.4% versus 90.9%), with elevated central glucose upon admission (197.7 mg/dl versus 155.9 mg/dl, p = 0.089) and at discharge (185.2 mg/dl versus 134 mg/dl, p = 0.038). The mean hypoxemia level upon hospital admission was 81% in patients who died due to COVID-19 complications and 88% in patients who survived (p = 0.026); at the time of discharge, hypoxemia levels were also different between the groups (68% versus 92%, p ≤ 0.001). In vitro assays showed that the viability of A549 cells decreased (76.41%) as the glucose concentration increased, and the ACE2 gene was overexpressed 9.91-fold after 72 h (p ≤ 0.001). The relationship between hyperglycemia and COVID-19 in hospitalized patients with COVID-19 plays an important role in COVID-19-related complications and the outcome for these patients. In patients with chronic and/or sustained hyperglycemia, the upregulation of ACE2, and its potential glycation and malfunction, could be related to complications observed in patients with COVID-19.
Databáze: MEDLINE